HEMATOPOETIC STEM CELL TRANSPLANTATION WITH CURRENT PERSPECTIVE IS SAFE FOR MUCOPOLYSACCHARIDOSIS TYPE VI PATIENTS

Abstract

50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Glasgow, SCOTLAND, APR 14-17, 2024